ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,084.07
-1.03%
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs Yen
158.095
0.00%
Brent Oil
88.165
0.00%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Akari Therapeutics PLC (AKTX)

  7. Akari Therapeutics PLC (AKTX) ニュース

AKTX Akari Therapeutics PLC

1.185
-0.005 (-0.42%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Akari Therapeutics PLC AKTX NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
Upgrade Icon
-0.005 -0.42% 1.185 06:16:11
始値 安値 高値 終値 前日終値
1.19 1.17 1.20 1.185 1.19
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/1601:53PRNUSKuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to..
2024/3/1206:25EDGAR2Form 425 - Prospectuses and communications, business..
2024/3/1206:24EDGAR2Form 8-K - Current report
2024/3/0606:57EDGAR2Form 425 - Prospectuses and communications, business..
2024/3/0522:34EDGAR2Form 425 - Prospectuses and communications, business..
2024/3/0522:28EDGAR2Form 8-K - Current report
2024/1/1007:25EDGAR2Form D - Notice of Exempt Offering of Securities
2024/1/0502:34EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/1/0309:56EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0309:49EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0308:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0308:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0306:30EDGAR2Form 8-K - Current report
2023/12/0122:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1622:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2805:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/10/2106:00EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/10/2105:29EDGAR2Form POS AM - Post-Effective amendments for registration..
2023/10/2105:28EDGAR2Form POS AM - Post-Effective amendments for registration..
2023/10/2105:23EDGAR2Form F-3 - Registration statement by foreign private issuers
2023/10/1305:43EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/9/2921:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/2121:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/0522:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/1821:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/1521:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/0221:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/2721:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/2521:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/1921:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/1321:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/1121:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/0805:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/0621:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/0521:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/0105:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/5/1705:05GLOBEAspira Women’s Health Names Torsten Hombeck as Chief..

最近閲覧した銘柄

NASDAQ
AKTX
Akari Therapeutics
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有